The transgenic construct consists of tamoxifen-inducible cre recombinase (cre fused to two mutated estrogen receptors; MER-cre-MER) under the control of a Nanos2 enhancer element. (J:152220)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count